Samsung Medical Center
Targeted therapy in the Republic of Korea typically costs from AUD $7,908 to AUD $16,535 per treatment cycle. Final expenses depend on the medication type, hospital tier, and necessary diagnostic monitoring. In Australia, patients often face costs around AUD $16,103, meaning travelling to South Korea can provide savings of approximately 51%. Most packages include specialist consultations, the targeted drugs, and onsite monitoring.
Bookimed Expert Insight: Choosing a digitalised facility like Seoul National University Bundang Hospital (SNUBH) provides superior coordination for international patients. Their BESTcare system ensures precise drug tracking, which is vital for high-cost targeted regimes. For those seeking value, Gachon University Gil Medical Center in Incheon provides competitive rates only one hour from the international airport.
| Republic of Korea | Thailand | Turkey | |
| Targeted therapy | from AUD $7,908 | from AUD $10,065 | from AUD $1,438 |
| Lutetium-177 therapy | from AUD $19,410 | from AUD $17,254 | from AUD $12,653 |
| Oncothermia | - | from AUD $5,176 | from AUD $647 |
| Actinium-225 Therapy | - | from AUD $35,945 | from AUD $33,005 |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
When considering Targeted therapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.
Common side effects of targeted therapy in South Korea include acne-like skin rashes, persistent fatigue, and gastrointestinal issues. Diarrhoea is one such issue. Specialist oncology teams at JCI-accredited Seoul centres closely monitor these reactions. This helps prevent treatment interruptions. Patients may also experience high blood pressure or joint aches.
Bookimed Expert Insight: Leading Seoul hospitals offer same-day consultations and tests for new cancer cases. Korea University Anam Hospital is one such centre. This speed is vital for managing side effects. Fast access allows oncologists to adjust dosages immediately. This can happen if adverse reactions appear, such as hepatotoxicity or pneumonitis.
Patient Consensus: South Korean clinics provide detailed protocols for managing side effects. These include severe fatigue and musculoskeletal pain. Patients suggest arranging a support system early. Exhaustion can be more intense than expected during the long treatment period.
In South Korean clinics, targeted therapy focuses on specific molecular markers that drive cancer growth. Chemotherapy, however, is systemic and affects all rapidly dividing cells. Clinicians at JCI-accredited centres like Severance Hospital use genetic profiling. They then customise molecular plans that spare healthy tissue.
Bookimed Expert Insight: Major Seoul centres like Korea University Anam Hospital offer same-day consultations. They also provide tests for new cancer patients. This speed is vital for targeted therapy. Molecular results dictate whether a patient starts specific inhibitors or requires traditional chemotherapy first.
Patient Consensus: Patients find that South Korean specialists prioritise genetic profiling. Doctors then decide if targeted therapy works for the patient's specific cancer biology. Clinical standards in Seoul hospitals are highly regarded. Many patients highlight the availability of modern drugs alongside traditional treatments.
International patients can access targeted therapy in South Korea at major oncology centres. Facilities such as Severance Hospital and Samsung Medical Center provide precision medicine. This includes specialised treatments like Lutetium-177 therapy for resistant tumours. Most top-tier centres hold Joint Commission International (JCI) accreditation.
Bookimed Expert Insight: Basic targeted therapy costs from $5,500 to $11,500. However, many patients overlook speed of access. Data suggests clinics like Korea University Anam Hospital offer same-day consultations for new cancer patients. This is a massive advantage when avoiding the months-long waiting lists common in Australian public systems.
Patient Consensus: South Korea offers incredible medical technology comparable to top global centres. Patients suggest using medical platforms to secure appointments quickly. Starting treatment within a month significantly improves outcomes.
South Korea houses several of the world's top-ranked oncology centres. These include Samsung Medical Center and Asan Medical Center in Seoul. These facilities specialise in molecular profiling and targeted therapies for complex cancers. They often hold Joint Commission International (JCI) accreditation or equivalent quality standards.
Bookimed Expert Insight: Data shows that Seoul National University Hospital outperforms international benchmarks. It has an 86.5% anus preservation rate in colon cancer cases. These centres use digital systems like BESTcare. They typically achieve higher precision in targeted drug delivery than traditional hospital settings.
Patient Consensus: Seoul is home to three of the world's top ten cancer hospitals. Patients suggest booking months in advance. Tertiary university-affiliated hospitals have high demand from international visitors.
Molecular testing serves as the essential diagnostic gateway for precision oncology in South Korea. Specialists use Next-Generation Sequencing (NGS) to identify actionable genetic alterations. These results help match advanced solid tumours with specific targeted drugs. This data-driven approach allows clinics in Seoul to personalise treatment regimens for better patient outcomes.
Bookimed Expert Insight: South Korea leads in precision oncology efficiency, with clinics like Korea University Anam Hospital offering same-day consultations and tests. This speed is critical because molecular testing results typically dictate the entire therapeutic pathway. Targeted therapy costs between $5,500 and $11,500. Still, the rapid diagnostic turnaround significantly reduces travel time for international patients.
Patient Consensus: Molecular diagnostics are now the primary tool for selecting drugs in South Korea, especially for stomach cancer. Patients find that a comprehensive genomic profile before treatment is vital. It ensures they receive the most effective precision drug.
South Korea treats various cancers with targeted therapy. This includes HER2-positive breast and gastric cancers, lung cancer, and blood cancers. Leading Seoul hospitals use antibody-drug conjugates and domestically developed CAR-T treatments. These therapies target specific genetic mutations like EGFR, ALK, and ROS1 to stop cancer growth.
Bookimed Expert Insight: Most clinics focus on drug-based targeted therapy. However, South Korean centres like Seoul National University Bundang Hospital lead in surgical targeting. They perform 90% of stomach cancer surgeries laparoscopically. This precision approach often results in a 91.9% survival rate for breast cancer patients.
Patient Consensus: South Korean oncologists use genetic profiling to match treatments to specific tumour mutations. Patients find the experience highly efficient. This stems from integrating targeted drugs with robotic surgery and 24/7 interpreter services.